Colon cancer patient information seeking and the adoption of targeted therapy for on-label and off-label indications

Cancer

Volumn 115, Issue 7, 2009, Pages 1424-1434

  Gray, Stacy W ^a   Armstrong, Katrina ^b,c   Demichele, Angela ^b,c   Schwartz, J Sanford ^b,c   Hornik, Robert C ^c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cancer survivor; Communication; Diffusion and adoption; Information seeking; Off label drug use; Targeted therapy

Indexed keywords

BEVACIZUMAB; CETUXIMAB;

ADULT; AGED; ARTICLE; AWARENESS; CANCER PATIENT; COLON CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG APPROVAL; DRUG INDICATION; DRUG USE; FEMALE; FOOD AND DRUG ADMINISTRATION; HEALTH SURVEY; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; METASTASIS; OFF LABEL DRUG USE; OUTCOME ASSESSMENT; PATIENT INFORMATION; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SELF REPORT;

ACCESS TO INFORMATION; ADULT; AGED; ANTIBODIES, MONOCLONAL; COLONIC NEOPLASMS; CONSUMER HEALTH INFORMATION; DRUG DELIVERY SYSTEMS; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES;

EID: 63449130309     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24186     Document Type: Article

References (56)

1. Balint J, Shelton W. Regaining the initiative. Forging a new model of the patient-physician relationship. JAMA. 1996;275:887-891.
2. Laine C, Davidoff F. Patient-centered medicine. A professional evolution. JAMA. 1996;275:152-156.
3. Rimal RN, Ratzan SC, Arnston P, Freimuth VS. Reconcep- tualizing the "patient": health care promotion as increasing citizens' decision-making competencies. Health Commun. 1997;9:61-74.
4. Johnson JD. Cancer-Related Information Seeking. Cresskill, NJ: Hampton Press, Inc.; 1997.
5. Kaplan RM, Frosch DL. Decision making in medicine and health care. Annu Rev Clin Psychol. 2005;1:525-556.
6. Hesse BW, Moser RP, Rutten LJF, Kreps GL. The Health Information National Trends Survey: research from the baseline. J Health Commun. 2006;11(suppl 1):vii-xvi.
7. Viswanath K. Science and society: the communications revolution and cancer control. Nat Rev Cancer. 2005;5:828-835.
8. Eysenbach G. The impact of the Internet on cancer outcomes. CA Cancer J Clin. 2003;53:356-371.
9. Anderson JG, Rainey MR, Eysenbach G. The impact of CyberHealthcare on the physician-patient relationship. J Med Syst. 2003;27:67-84.
10. Fox S, Rainie L. The Online Health Care Revolution: How the Web Helps Americans Take Better Care of Themselves: The Pew Internet and American Life Project, Volume 2007. Washington, DC: Pew Charitable Trusts; 2000.
11. Helft PR, Hlubocky F, Daugherty CK. American oncologists' views of Internet use by cancer patients: a mail survey of American Society of Clinical Oncology members. J Clin Oncol. 2003;21:942-947.
12. Newnham GM, Burns WI, Snyder RD, et al. Attitudes of oncology health professionals to information from the Internet and other media. Med J Aust. 2005;183:197-200.
13. Hiatt RA, Rimer BK. A new strategy for cancer control research. Cancer Epidemiol Biomarkers Prev. 1999;8:957-964.
14. Berndt ER, Bhattacharjya A, Mishol DN, Arcelus A, Lasky T. An analysis of the diffusion of new antidepressants: variety, quality, and marketing efforts. J Ment Health Policy Econ. 2002;5:3-19.
15. Huckman RS, Pisano GP. Turf battles in coronary revascularization. N Engl JMed. 2005;352:857-859.
16. Phillips KA, Van Bebber SL. Regulatory perspectives on pharmacogenomics: a review of the literature on key issues faced by the United States Food and Drug Administration. Med Care Res Rev. 2006;63:301-326.
17. Stanley A, DeLia D, Cantor JC. Racial disparity and technology diffusion: the case of cardioverter defibrillator implants, 1996-2001. J Natl Med Assoc. 2007;99:201- 207.
18. Ferris TG, Kuhlthau K, Ausiello J, Perrin J, Kahn R. Are minority children the last to benefit from a new technology? Technology diffusion and inhaled corticosteriods for asthma. Med Care. 2006;44:81-86.
19. Vanderveen KA, Paterniti DA, Kravitz RL, Bold RJ. Diffusion of surgical techniques in early stage breast cancer: variables related to adoption and implementation of sentinel lymph node biopsy. Ann Surg Oncol. 2007;14:1662-1669.
20. Wilson CB. Adoption of new surgical technology. BMJ. 2006;332:112-114.
21. Coleman J, Katz E, Menzel H. The diffusion of an innovation among physicians. Sociometry. 1957;20:253-270.
22. Berndt ER, Bui L, Reiley DR, Urban GL. Information, marketing, and pricing in the US antiulcer drug market. Am Econ Rev. 1995;85:100-105.
23. Geller G, Tambor ES, Bernhardt BA, Rodgers J, Holtzman NA. Houseofficers' reactions to media coverage about the sequencing of the human genome. Soc Sci Med. 2003;56:2211-2220.
24. Phillips DP, Kanter EJ, Bednarczyk B, Tastad PL. Importance of the lay press in the transmission of medical knowledge to the scientific community. N Engl J Med. 1991;325:1180-1183.
25. Bass SB, Ruzek SB, Gordon TF, Fleisher L, McKeown- Conn N, Moore D. Relationship of Internet health information use with patient behavior and self-efficacy: experiences of newly diagnosed cancer patients who contact the National Cancer Institute's Cancer Information Service. J Health Commun. 2006;11:219-236.
26. Czaja R, Manfredi C, Price J. The determinants and consequences of information seeking among cancer patients. J Health Commun. 2003;8:529-562.
27. Shim M, Kelly B, Hornik R. Cancer information scanning and seeking behavior is associated with knowledge, lifestyle choices, and screening. J Health Commun. 2006;11(suppl 1):157-172.
28. Pentz RD, Flamm AL, Sugarman J, et al. Study of the media's potential influence on prospective research participants' understanding of and motivations for participation in a high-profile phase I trial. J Clin Oncol. 2002;20:3785-3791.
29. Dillman D. Mail and Internet Surveys: The Tailored Design Method, 2nd ed. New York, NY: John Wiley & Sons; 2000.
30. American Association for Public Opinion Research. Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys, 4th ed. Lenexa, Kan: American Association for Public Opinion Research; 2006.
31. Kravitz RL, Epstein RM, Feldman MD, et al. Influence of patients' requests for direct-to-consumer advertised antide- pressants: a randomized controlled trial. JAMA. 2005;293:1995-2002.
32. Mintzes B, Barer ML, Kravitz RL, et al. How does direct- to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ. 2003;169:405-412.
33. Weissman JS, Blumenthal D, Silk AJ, Zapert K, Newman M, Leitman R. Consumers' reports on the health effects of direct-to-consumer drug advertising [supplemental web exclusives]. Health Aff (Millwood). 2003;W3(suppl):82-95.
34. Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med. 2006;166:1021-1026.
35. Laetz T, Silberman G. Reimbursement policies constrain
36. the practice of oncology. JAMA. 1991;266:2996-2999.
37. Kocs D, Fendrick AM. Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience. Am J Manag Care. 2003;9:393-400; quiz 401-402.
38. Giantonio BJ, Catalano PJ, Meropol NJ, et al. Bevacizu-mab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol. 2007;25:1539- 1544.
39. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizu-mab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335-2342.
40. Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan- refractory metastatic colorectal cancer. N Engl J Med. 2004;351:337-345.
41. Grothey A. Biological therapy and other novel therapies in early-stage disease: are they appropriate? Clin Cancer Res. 2007;13(22 pt 2):6909s-6912s.
42. Stafford RS. Regulating off-label drug use-rethinking the role of the FDA. N Engl J Med. 2008;358:1427-1429.
43. Dai C, Stafford RS, Alexander GC. National trends in cyclooxygenase-2 inhibitor use since market release: nonselective diffusion of a selectively cost-effective innovation. Arch Intern Med. 2005;165:171-177.
44. Heavey S. US lawmakers seek J&J, Amgen anemia drug records. Washington, DC: Reuters; 2008. Available at: http://www.reuters.com/article/ marketsNews/idUSN0130607820080401. Accessed on September 23, 2008.
45. Mayer RJ. Two steps forward in the treatment of colorectal cancer. N Engl J Med. 2004;350:2406-2408.
46. Irving L, Klegar-Levy K, Everette D. Falling Through the Net: Defining the Digital Divide. A Report on the Telecommunications and Information Technology Gap in America. Washington, DC: National Telecommunications and Information Administration, U.S. Department of Commerce; 1999.
47. Brodie M, Flournoy RE, Altman DE, Blendon RJ, Benson JM, Rosenbaum MD. Health information, the Internet, and the digital divide. Health Aff (Millwood). 2000;19:255- 265.
48. Ramanadhan S, Viswanath K. Health and the information nonseeker: a profile. Health Commun. 2006;20:131-139.
49. Rutten LJ, Squiers L, Hesse B. Cancer-related information seeking: hints from the 2003 Health Information National Trends Survey (HINTS). J Health Commun. 2006;11(suppl 1):147-156.
50. Carlsson M. Cancer patients seeking information from sources outside the health care system. Support Care Cancer. 2000;8:453-457.
51. Mellink WA, Dulmen AM, Wiggers T, Spreeuwenberg PM, Eggermont AM, Bensing JM. Cancer patients seeking a second surgical opinion: results of a study on motives, needs, and expectations. J Clin Oncol. 2003;21:1492-1497.
52. Selman AE, Niemann TH, Fowler JM, Copeland LJ. Quality assurance of second opinion pathology in gynecologic oncology. Obstet Gynecol. 1999;94:302-306.
53. Mellink WA, Henzen-Logmans SC, Bongaerts AH, Ooijen BV, Rodenburg CJ, Wiggers TH. Discrepancy between second and first opinion in surgical oncological patients. Eur J Surg Oncol. 2006;32:108-112.
54. Solomon DH, Stedman M, Licari A, Weinblatt ME, Maher N, Shadick N. Agreement between patient report and medical record review for medications used for rheumatoid arthritis: the accuracy of self-reported medication information in patient registries. Arthritis Rheum. 2007;57:234-239.
55. Klungel OH, de Boer A, Paes AH, Herings RM, Seidell JC, Bakker A. Agreement between self-reported antihyper- tensive drug use and pharmacy records in a population- based study in the Netherlands. Pharm World Sci. 1999;21:217-220.
56. Klungel OH, de Boer A, Paes AH, Seidell JC, Bakker A. Cardiovascular diseases and risk factors in a population- based study in the Netherlands: agreement between questionnaire information and medical records. Neth J Med. 1999;55:177-183.